The clinical utilization of ketamine is swiftly increasing, underscoring the necessity for standardized pointers to immediate its use. This is particularly important given that ketamine use for TRD is at this time not authorized by the FDA Even with a big entire body of evidence supporting its efficacy and security. At the moment, the very long-ex